Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
S Fabián Lerner, Francesco Oddone, Da-Wen Lu, Ana Sanseau, Merce Guarro, Antonia Ridolfi & Douglas Hubatsch. (2019) Maximum Medical Therapy: Brinzolamide/Brimonidine And Travoprost/Timolol Fixed-Dose Combinations In Glaucoma And Ocular Hypertension. Clinical Ophthalmology 13, pages 2411-2419.
Read now
Read now
Vassilios Kozobolis, Aristeidis Konstantinidis, Haris Sideroudi & Miguel Teus. (2018) Efficacy of the travoprost/timolol fixed combination versus the concomitant use of travoprost 0.004% and timolol 0.1% gel formulation. Clinical Ophthalmology 12, pages 2393-2398.
Read now
Read now
Tadashi Nakano, Shiro Mizoue, Nobuo Fuse, Aiko Iwase, Shun Matsumoto & Keiji Yoshikawa. (2017) Fixed combination of travoprost and timolol maleate reduces intraocular pressure in Japanese patients with primary open-angle glaucoma or ocular hypertension: analysis by prostaglandin analogue. Clinical Ophthalmology 11, pages 55-61.
Read now
Read now
Marcelo Lopes da Silva Jordão, Marcelo Hatanaka, Abayomi Ogundele, Maria Rosa Bet de Moraes Silva & Roberto Murad Vessani. (2014) Safety and efficacy of fixed-combination travoprost/timolol in patients with open-angle glaucoma or ocular hypertension not controlled with timolol monotherapy. Clinical Ophthalmology 8, pages 1527-1534.
Read now
Read now
Purvi Bhagat, Kalyani Sodimalla, Chandrima Paul, Surinder S Pandav, Ganesh V Raman, Rengappa Ramakrishnan, Abhijeet Joshi & Atul Raut. (2014) Efficacy and safety of benzalkonium chloride-free fixed-dose combination of latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Clinical Ophthalmology 8, pages 1241-1252.
Read now
Read now
Marisa Meloni, Giampiero Cattaneo & Barbara De Servi. (2012) Corneal epithelial toxicity of antiglaucoma formulations: in vitro study of repeated applications. Clinical Ophthalmology 6, pages 1433-1440.
Read now
Read now
Articles from other publishers (8)
Victoria Toumanidou, Asterios Diafas, Nikolaos Georgiadis & Ioannis Tsinopoulos. (2023) Fixed versus Unfixed Combination of Topical Latanoprost/Timolol for Glaucoma: An Observational Study Investigating the Level of Adherence and Ocular Surface Health. Journal of Clinical Medicine 12:9, pages 3137.
Crossref
Crossref
Sapna Sinha, Wesam Shamseldin Shalaby, Wendy W. Liu, Reza Razeghinejad & L. Jay Katz. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
612
661
.
Laura E Downie, Sueko M Ng, Kristina B Lindsley & Esen K Akpek. (2019) Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Kenji Inoue, Kyoko Ishida & Goji Tomita. (2018) Effectiveness and safety of switching from prostaglandin analog monotherapy to prostaglandin/timolol fixed combination therapy or adding ripasudil. Japanese Journal of Ophthalmology 62:4, pages 508-516.
Crossref
Crossref
Kenji Inoue, Mieko Masumoto, Kyoko Ishida & Goji Tomita. (2017) Efficacy and Safety of Switching from Prostaglandin Analog Therapy to Prostaglandin / Timolol Fixed Combination or Prostaglandin / Brimonidine Therapy. The Open Ophthalmology Journal 11:1, pages 156-163.
Crossref
Crossref
Simon Fabian Lerner, Ki Ho Park, Douglas A. Hubatsch, Valeriy Erichev, Jose A. Paczka & Timothy V. Roberts. (2017)
Efficacy and Tolerability of Travoprost 0.004
/Timolol 0.5
Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
. Journal of Ophthalmology 2017, pages 1-8.
Crossref
Crossref
Tadashi Nakano, Shiro Mizoue, Nobuo Fuse, Aiko Iwase, Shun Matsumoto & Keiji Yoshikawa. (2015) Fixed Combination of Travoprost and Timolol Maleate Reduces Intraocular Pressure in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Prospective Multicenter Open-Label Study. Advances in Therapy 32:9, pages 823-837.
Crossref
Crossref
Italo Giuffre. (2012) Comparative Evaluation of the Efficacy of the Bimatoprost 0.03%, Brimonidine 0.2%, Brinzolamide 1%, Dorzolamide 2%, and Travoprost 0.004%/Timolol 0.5%-Fixed Combinations in Patients Affected by Open-Angle Glaucoma. Open Journal of Ophthalmology 02:04, pages 122-126.
Crossref
Crossref